Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-23T06:49:38.734Z Has data issue: false hasContentIssue false

Case 11: How slow can you go? Selective serotonin reuptake inhibitor (SSRI) withdrawal and discontinuation in an adolescent

Published online by Cambridge University Press:  09 February 2024

Jeffrey R. Strawn  and
Stephen M. Stahl
Jeffrey R. Strawn
Affiliation:
University of Cincinnati, Ohio
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

When discontinuing an SSRI in an adolescent with major depressive disorder following 12 months of treatment, the highest risk of relapse occurs:

Type
Chapter
Information
Case Studies: Stahl's Essential Psychopharmacology
Children and Adolescents
 , pp. 173 - 184
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Emslie, G. J., Heiligenstein, J. H., Hoog, S. L., et al. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 2004; 43(11): 1397–405. https://doi.org/10.1097/01.chi.0000140453.89323.57Google Scholar
Emslie, G. J., Kennard, B. D., Mayes, T. L., et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry 2008; 165(4): 459–67. https://doi.org/10.1176/appi.ajp.2007.07091453Google Scholar
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., Offidani, E. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom 2015; 84(2): 72–81. https://doi.org/10.1159/000370338Google Scholar
Ginsburg, G. S., Becker-Haimes, E. M., Keeton, C., et al. Results from the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): primary anxiety outcomes. J Am Acad Child Adolesc Psychiatry 2018; 57(7): 471–80. https://doi.org/10.1016/j.jaac.2018.03.017Google Scholar
Harvey, B. H., McEwen, B. S., Stein, D. J. Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression. Biol Psychiatry 2003; 54(10): 1105–17. https://doi.org/10.1016/s0006-3223(03)00528-6Google Scholar
Hathaway, E. E., Walkup, J. T., Strawn, J. R. Antidepressant treatment duration in pediatric depressive and anxiety disorders: how long is long enough? Curr Probl Pediatr Adolesc Health Care 2017; 48(2): 31–39. https://doi.org/10.1016/j.cppeds.2017.12.002Google Scholar
Horowitz, M. A., Taylor, D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry 2019; 6(6): 538–46. https://doi.org/10.1016/S2215-0366(19)30032-XGoogle Scholar
Kennard, B. D., Emslie, G. J., Mayes, T. L., et al. Sequential treatment with fluoxetine and relapse-prevention CBT to improve outcomes in pediatric depression. Am J Psychiatry 2014; 171(10): 1083–90. https://doi.org/10.1176/appi.ajp.2014.13111460Google Scholar
Rickels, K., Etemad, B., Khalid-Khan, S., et al. Time to relapse after 6 and 12 months’ treatment of generalized anxiety disorder with venlafaxine extended release. Arch Gen Psychiatry 2010; 67(12): 1274–81. https://doi.org/10.1001/archgenpsychiatry.2010.170Google Scholar
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., Krebs, W. B. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 1998; 44(2): 77–87. https://doi.org/10.1016/s0006-3223(98)00126-7Google Scholar
Shapiro, B. B. Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs. Psychopharmacology (Berl) 2018; 235(9): 2779–81. https://doi.org/10.1007/s00213-018-4995-4Google Scholar
Strawn, J. R., Lu, L., Peris, T. S., Levine, A., Walkup, J. T. Research review: pediatric anxiety disorders – what have we learnt in the last 10 years? J Child Psychol Psychiatry Allied Discipl 2021; 62(2): 114–39. https://doi.org/10.1111/jcpp.13262Google Scholar
Strawn, J. R., Mills, J. A., Poweleit, E. A., Ramsey, L. B., Croarkin, P. E. Adverse effects of antidepressant medications and their management in children and adolescents. Pharmacotherapy 2023. https://doi.org/10.1002/phar.2767. Epub ahead of print. PMID: 36651686.Google Scholar
Strawn, J. R., Mills, J. A., Suresh, V., et al. Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety. J Affect Dis 2022; 298(Pt A): 292–300. https://doi.org/10.1016/j.jad.2021.10.047Google Scholar
Strawn, J. R., Poweleit, E. A., Uppugunduri, C. R. S., Ramsey, L. B. Pediatric therapeutic drug monitoring for selective serotonin reuptake inhibitors. Front Pharmacol 2021; 12: 749692. https://doi.org/10.3389/fphar.2021.749692Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×